Please use this identifier to cite or link to this item:
https://hdl.handle.net/10923/17876
Type: | Article |
Title: | The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels |
Author(s): | WERUTSKY, GUSTAVO MALUF, FERNANDO COTAIT CRONEMBERGER, EDUARDO HENRIQUE CARRERA SOUZA, VINICIUS DOS SANTOS MARTINS, SUELEN PATRICIA PEIXOTO, FÁBIO SMALETZ, OREN SCHUTZ, FÁBIO HERCHENHORN, DANIEL SANTOS, TELMA MAVIGNIER CARCANO, FLAVIO QUEIROZ MUNIZ, DAVID NUNES FILHO, PAULO R. S. ZAFFARONI, FACUNDO BARRIOS, CARLOS André Poisl Fay |
In: | BMC CANCER |
Issue Date: | 2019 |
Volume: | 19 |
Issue: | 1 |
First page: | 487 |
URI: | https://hdl.handle.net/10923/17876 |
DOI: | DOI:10.1186/s12885-019-5709-y |
ISSN: | 1471-2407 |
Appears in Collections: | Artigo de Periódico
|
All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.